Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells.

MLA

Bhere, Deepak, et al. “Target Receptor Identification and Subsequent Treatment of Resected Brain Tumors with Encapsulated and Engineered Allogeneic Stem Cells.” Nature Communications, vol. 13, no. 1, May 2022, p. 2810. EBSCOhost, https://doi.org/10.1038/s41467-022-30558-3.

APA

Bhere, D., Choi, S. H., van de Donk, P., Hope, D., Gortzak, K., Kunnummal, A., Khalsa, J., Revai Lechtich, E., Reinshagen, C., Leon, V., Nissar, N., Bi, W. L., Feng, C., Li, H., Zhang, Y. S., Liang, S. H., Vasdev, N., Essayed, W. I., Quevedo, P. V., … Shah, K. (2022). Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature Communications, 13(1), 2810. https://doi.org/10.1038/s41467-022-30558-3

Chicago

Bhere, Deepak, Sung Hugh Choi, Pim van de Donk, David Hope, Kiki Gortzak, Amina Kunnummal, Jasneet Khalsa, et al. 2022. “Target Receptor Identification and Subsequent Treatment of Resected Brain Tumors with Encapsulated and Engineered Allogeneic Stem Cells.” Nature Communications 13 (1): 2810. doi:10.1038/s41467-022-30558-3.